A carregar...
Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
BACKGROUND: High on-treatment ADP platelet reactivity (HPR) measured by VerifyNow P2Y12 assay (VN) is an established risk factor for ischemic events after percutaneous coronary intervention (PCI). We hypothesized that routine use of VN at time of PCI in clinical practice may affect choice of P2Y12 a...
Na minha lista:
| Publicado no: | Clin Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170549/ https://ncbi.nlm.nih.gov/pubmed/32368161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S242675 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|